Drug Shortage Report for LORAZEPAM

Last updated on 2024-03-02 History
Report ID 135879
Drug Identification Number 02351099
Brand name LORAZEPAM
Common or Proper name LORAZEPAM
Company Name SANIS HEALTH INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LORAZEPAM
Strength(s) 2.0MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2021-09-30
Actual start date 2021-08-12
Estimated end date Unknown
Actual end date 2024-03-01
Shortage status Resolved
Updated date 2024-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-03-02 English Compare
v11 2024-03-01 French Compare
v10 2024-03-01 English Compare
v9 2021-12-16 English Compare
v8 2021-08-13 English Compare
v7 2021-08-12 French Compare
v6 2021-08-12 English Compare
v5 2021-05-05 French Compare
v4 2021-05-05 English Compare
v3 2021-05-02 English Compare
v2 2021-03-18 French Compare
v1 2021-03-18 English Compare

Showing 1 to 12 of 12